Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2027
Halifax, Nova Scotia--(Newsfile Corp. - November 12, 2026) - Appili Therapeutics Inc. (NEX: APLI.H) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company building a National Security Healthcare platform focused on dual-use medical technologies, today announced its financial and operational results for the second quarter of its fiscal year 2027, which ended on September 30, 2026. All figures are in Canadian dollars unless otherwise stated.Revised Business Strategy Appili is...